Business Wire

Work Connected with the Olympus Scientific Cloud

Del

The new Olympus Scientific Cloud expands the capabilities of the EPOCH® 6LT flaw detector and Vanta handheld XRF analyzer at no extra cost, with more features planned in the coming months. A suite of new capabilities, including wireless software updates, easy data backups, and real-time screen sharing for Vanta analyzers help make your work faster and more efficient.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171024005101/en/

Work Connected with the Olympus Scientific Cloud (Photo: Business Wire)

Work Connected with the Olympus Scientific Cloud (Photo: Business Wire)

Olympus is constantly improving the software of our instruments. The Olympus Scientific Cloud (OSC) enables users to wirelessly download the latest software updates directly to their instrument without having to use a PC interface program. When an update for the Vanta analyzer is available, a notification will appear in the device’s user interface, prompting the user to download. EPOCH 6LT users can check the Cloud web application for updates. For fleet managers, this functionality helps ensure that all of the EPOCH 6LT flaw detectors and Vanta analyzers in their fleet are operating on the same software version for reliable, reproducible results.

Once data has been acquired, the Olympus Scientific Cloud makes it easy to back it up and share it with others. Operators can wirelessly upload their data to the Cloud, even while they are still in the field. Users no longer have to worry about maintaining a large backlog of files on their instrument or running out of space. Once the data is in the Cloud, colleagues back in the office or on the other side of the world can see the data for fast, efficient collaboration. The data files can also be transferred in open formats, like CSV, so users can easily access their data using their preferred software.

The OSC has powerful new management functionality. Fleet managers can monitor health parameters of their devices, such as active time, error logs, and temperature.* Managers can also use the OSC to keep track of how much each device is used to help ensure that the work is distributed evenly across the fleet. If an instrument needs to be serviced, the Cloud helps the Olympus service center know what components and software need updating or servicing to minimize downtime.

For Vanta analyzers, the OSC offers additional benefits, including:

  • Screen sharing: users in the field can share their analyzer’s screen with decision-makers back in the office.
  • Advanced fleet management: managers can track the last reported physical location of all of their analyzers.
  • Automatic data uploads: data automatically uploads (or is sent) to the Cloud as soon as you complete a test.

The benefits and functionality of the Olympus Scientific Cloud are paired with leading-edge security features. With a network of data centers located all over the world, users can be assured that their data is stored securely and locally. All data uploaded to the Olympus Scientific Cloud remains the property of the customer; Olympus does not share or use customer data that is stored in the Cloud.

*Health data varies per instrument.

About Olympus

Olympus Corporation operates in industrial, medical, and consumer markets, specializing in optics, electronics, and precision engineering. Olympus is a world-leading manufacturer of innovative test and measurement solutions that are used in industrial and research applications ranging from aerospace, power generation, petrochemical, civil infrastructure, and automotive to consumer products.

For more information about the Olympus Scientific Cloud and Olympus’ full line of nondestructive testing products, contact a sales representative or visit http://www.olympus-ims.com/.

Olympus and EPOCH are registered trademarks, and Vanta is a trademark of Olympus Corporation.

Contact information

Olympus Corporation
Calvin Jory, 781-419-3549
Calvin.Jory@olympus-ossa.com
or
Michelle Wright, 781-419-3664
Michelle.Wright@olympus-ossa.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar15.12.2017 22:13Pressemelding

Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 12:34Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712

Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 12:21Pressemelding

Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr

Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 11:38Pressemelding

A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L

Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 11:00Pressemelding

Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a

AML BitCoin Enters Phase II of ICO15.12.2017 09:00Pressemelding

NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom